rs606231198
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_001032382.2(PQBP1):c.334_354del(p.Gly113_Arg119del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000784 in 1,208,929 control chromosomes in the GnomAD database, including 3 homozygotes. There are 426 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00046 ( 1 hom., 17 hem., cov: 21)
Exomes 𝑓: 0.00082 ( 2 hom. 409 hem. )
Consequence
PQBP1
NM_001032382.2 inframe_deletion
NM_001032382.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
PQBP1 (HGNC:9330): (polyglutamine binding protein 1) This gene encodes a nuclear polyglutamine-binding protein that is involved with transcription activation. The encoded protein contains a WW domain. Mutations in this gene have been found in patients with Renpenning syndrome 1 and other syndromes with X-linked cognitive disability. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
?
Nonframeshift variant in NON repetitive region in NM_001032382.2.
BP6
?
Variant X-48902256-AGCCATGACAAGTCGGACAGGG-A is Benign according to our data. Variant chrX-48902256-AGCCATGACAAGTCGGACAGGG-A is described in ClinVar as [Likely_benign]. Clinvar id is 10984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
?
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000461 (51/110709) while in subpopulation SAS AF= 0.00698 (18/2578). AF 95% confidence interval is 0.00451. There are 1 homozygotes in gnomad4. There are 17 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Hemizygotes in GnomAd at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PQBP1 | NM_001032382.2 | c.334_354del | p.Gly113_Arg119del | inframe_deletion | 5/7 | ENST00000447146.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PQBP1 | ENST00000447146.7 | c.334_354del | p.Gly113_Arg119del | inframe_deletion | 5/7 | 1 | NM_001032382.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000461 AC: 51AN: 110659Hom.: 1 Cov.: 21 AF XY: 0.000516 AC XY: 17AN XY: 32915
GnomAD3 genomes
?
AF:
AC:
51
AN:
110659
Hom.:
Cov.:
21
AF XY:
AC XY:
17
AN XY:
32915
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000944 AC: 173AN: 183289Hom.: 0 AF XY: 0.00146 AC XY: 99AN XY: 67777
GnomAD3 exomes
AF:
AC:
173
AN:
183289
Hom.:
AF XY:
AC XY:
99
AN XY:
67777
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000817 AC: 897AN: 1098220Hom.: 2 AF XY: 0.00112 AC XY: 409AN XY: 363584
GnomAD4 exome
AF:
AC:
897
AN:
1098220
Hom.:
AF XY:
AC XY:
409
AN XY:
363584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000461 AC: 51AN: 110709Hom.: 1 Cov.: 21 AF XY: 0.000516 AC XY: 17AN XY: 32975
GnomAD4 genome
?
AF:
AC:
51
AN:
110709
Hom.:
Cov.:
21
AF XY:
AC XY:
17
AN XY:
32975
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Renpenning syndrome Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2006 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 22, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 10, 2014 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | PQBP1: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Oct 25, 2023 | - - |
PQBP1-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 08, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at